
    
      The primary purpose of this study is to help answer the following research questions:

        -  Whether this drug can help symptoms of aggression and agitation in participants with
           Alzheimer's Disease.

        -  The safety of this drug and any side effects that might be associated with it.

        -  How this drug compares to placebo.

      During the 12-week period of this study, the participant will have an equal chance of
      receiving 1 of the 2 treatment groups: active drug or placebo.
    
  